Background
Background
Obstructive sleep apnea (OSA) is a common condition caused by intermittent airway collapse during sleep that results in repetitive hypoxia, arousal, poor quality of sleep and excessive daytime sleepiness. OSA is a risk factor for various cardiovascular conditions and in recent decades, OSA was associated with increased cardiovascular mortality in patients with the severe form of the disease without treatment. Therefore, adequate treatment with CPAP (Continuous Positive Airway Pressure) may improve survival. High-sensitivity cardiac troponin T and I ( hs cTnT and hs cTnI) is a new high sensitive method for risk stratification of cardiovascular diseases since they are released in the cardiac lesions.
Objective
The aim of our study was to evaluate the (hs cTnT and hs cTnI) methods and evaluate of cTnI conventional by two methods in patients with severe OSA before and after one year of effective treatment with CPAP.
Methods 36 patients of the Sleep Institute in Sao Paulo, with moderate to severe OSA, 22 men, with mean BMI¼ 30.207 9.12 Kg/m2 and age¼65.4 75.8 years, without other diseases were randomized and effectively treated with CPAP for 12 months. They all used CPAP for an average of 5 hours per night, nonsmoking and sedentary. Hs cTnT and conventional cTnI were analyzed by two methods, before and after 12 months of CPAP treatment. The hs cTnT was quantified with a Electrochemiluminescence (hs cTnT) Elecsys s -Roche/Elecsys) method of the third generation with a detection limit of 0.5 pg/mL. We also used immunoassay (Abbott/ ARCHITECT system) for its detection. To quantify cTnI ES conventional chemiluminescence (Vitros s -Ortho Clinical Diagnostics) was used, with 12 pg/mL the detection threshold. The second methods used was AccuTnIDx (Access/Beckman Counter) with detection limit of 10 pg/mL. Paired samples statistics and Wilcoxon test were performed for comparisons of results between methods before and after treatment.
Results
There was a significant effect of treatment with CPAP on the hs cTnT presented in the nonparametric statistical test Wilcoxon (Z¼ À1.955, p ¼0.05 and Z¼ À1.634, p ¼0.04). However no difference was found for cTnI conventional dosages.
Conclusion
CPAP treatment significantly reduced hs cTnT but not cTnI. Results suggest that hs cTnT is more sensitive to detect minor myocardial injuries detection. However it is not known the clinical meaning of this sensitive detection in OSA patients. 
Resumo
Neste caso, abordamos o tratamento clínico-cirúrgico em paciente idoso portador de apneia obstrutiva do sono e suas efetivas mudanças. O paciente, avaliado com a primeira polissonografia aos 59 anos de idade com um índice de apneia (IAH) severo 50,0/h e mínima de oxihemoglobina de 73%; apresentava queixas de cansaço, sonolência diurna, indisposição, dores de cabeça frequentes e dificuldade respiratória. Aos exames iniciais concluímos que o paciente também era portador de obesidade, vias aéreas superiores estreitadas e hipertensão arterial. Foi indicado tratamento nutricional, endocrinológico e de cirurgia esquelética visto que o paciente não havia se adaptado ao uso contínuo do CPAP (Pressão Positiva Contínua nas Vias Aéreas). Após tratamento nutricional e cirúrgico de avanço maxilo mandibular, com acompanhamento evolutivo através de imagens de 30 dias, 3 meses, 9 meses e 1 ano de pós operatório, momento em que o paciente realizou nova polissonografia (no mesmo laboratório que o inicial). Elucidamos melhoras significativas com relação ao índice de apneia (IAH inicial de 50,0/h e final de 4,6/h), mínima de oxihemoglobina com evolução final de 84% mín pontual, as queixas de roncopatia foram eliminadas, concluímos assim que a evolução clínica do paciente foi satisfatória. Averiguamos então que mesmo em condições onde o paciente tenha uma idade mais senil, se o diagnóstico e o tratamento forem coerentes aos sinais e sintomas, os resultados póstratamentos são eficientes. http://dx.doi.org/10. 1016/j.slsci.2016.02.134 Abstracts of XV Brazilian Sleep Congress / Sleep Science 8 (2015) 169-255
